Three years after undergoing gene therapy, his ‘last shot’ hit the target

Thursday, February 21, 2019 - 18:50 in Health & Medicine

Brenden Whittaker didn’t agree to gene therapy lightly. But he had been so sick for so long that the risk of the first-time-ever procedure would be worth it if that meant finally getting well. “I really didn’t have any other options, health-wise,” Brenden said. “I’d been sick for four or five years. They’d done countless tests, countless treatments, and nothing was working. This was really, honestly, one of my last shots at getting healthy.” The antibiotics that had been the young Ohio man’s ally against infection were finally failing, and doctors had been increasingly resorting to surgery, cutting out an infected lobe of his liver, half a right lung. Though the surgeries worked, removing the infection along with tissue, by late 2015 Brenden, his doctor, and his mother, Becky Whittaker — an oncology nurse who had guarded his health since his infancy — knew there were only a few bullets remaining in...

Read the whole article on Harvard Science

More from Harvard Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net